Alerts will be sent to your verified email
Verify Email
KPL
|
Kwality Pharma
|
Bharat Parenterals
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
25.27 % | 12.73 % | 15.94 % |
|
5yr average Equity Multiplier
|
1.96 | 1.76 | 1.3 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 0.86 | 0.84 |
|
5yr Avg Net Profit Margin
|
11.66 % | 8.73 % | 14.61 % |
|
Price to Book
|
3.76 | 2.74 | 1.65 |
|
P/E
|
22.89 | 0.0 | 12.84 |
|
5yr Avg Cash Conversion Cycle
|
55.02 Days | 122.06 Days | 24.49 Days |
|
Inventory Days
|
67.04 Days | 46.56 Days | 42.89 Days |
|
Days Receivable
|
132.46 Days | 179.99 Days | 90.22 Days |
|
Days Payable
|
126.93 Days | 95.97 Days | 111.35 Days |
|
5yr Average Interest Coverage Ratio
|
16.13 | 22.68 | 58.2 |
|
5yr Avg ROCE
|
34.73 % | 16.02 % | 20.48 % |
|
5yr Avg Operating Profit Margin
|
23.23 % | 11.16 % | 18.48 % |
|
5 yr average Debt to Equity
|
0.46 | 0.26 | 0.0 |
|
5yr CAGR Net Profit
|
21.34 % | -9.67 % | 12.65 % |
|
5yr Average Return on Assets
|
12.96 % | 8.0 % | 12.28 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.83 % | 67.19 % | 49.78 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | -6.65 % | 5.7 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kwality Pharma
|
Bharat Parenterals
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Formulations Breakup
|
Formulations Breakup
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|